AR031662A1 - Nuevos derivados biciclicos de aminopirazinonas, su procedimiento de preparacion, composiciones farmaceuticas que las contienen y su utilizacion como inhibidores de proteasas de serina relacionadas con la tripsina - Google Patents
Nuevos derivados biciclicos de aminopirazinonas, su procedimiento de preparacion, composiciones farmaceuticas que las contienen y su utilizacion como inhibidores de proteasas de serina relacionadas con la tripsinaInfo
- Publication number
- AR031662A1 AR031662A1 ARP010105766A ARP010105766A AR031662A1 AR 031662 A1 AR031662 A1 AR 031662A1 AR P010105766 A ARP010105766 A AR P010105766A AR P010105766 A ARP010105766 A AR P010105766A AR 031662 A1 AR031662 A1 AR 031662A1
- Authority
- AR
- Argentina
- Prior art keywords
- aminopirazinones
- tripsine
- inhibitors
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 102000012479 Serine Proteases Human genes 0.000 title 1
- 108010022999 Serine Proteases Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- 101000712605 Theromyzon tessulatum Theromin Proteins 0.000 abstract 1
- 229940122388 Thrombin inhibitor Drugs 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000000592 heterocycloalkyl group Chemical group 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000003868 thrombin inhibitor Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Compuestos de formula (1), en la cual: R1 representa un átomo de hidrogeno o un grupo alquilo C1-6 lineal o ramificado, opcionalmente substituido por uno o más grupos, idénticos o diferentes, elegidos entre arilo, heteroarilo, cicloalquilo y heterocicloalquilo; el anillo A representa un ciclo saturado de 4 a 7 eslabones que pueden contener, además del átomo de nitrogeno, uno o dos heteroátomos elegidos entre O y S, y grupos -NR3, en el cual R3 representa un átomo de hidrogeno o un grupo alquilo C1-6 lineal o ramificado; n representa un entero tal como 1 <= n <= 6; R2 representa cualquiera de los grupos descriptos en la descripcion; sus isomeros, sus N-oxidos y sales de adicion farmacéuticamente aceptables de los mismos, con un ácido o base. Composicion farmacéutica de acuerdo a la presente, util como inhibidor de trombina.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0016321A FR2818277B1 (fr) | 2000-12-14 | 2000-12-14 | Nouveaux derives bicycliques d'amino-pyrazinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR031662A1 true AR031662A1 (es) | 2003-09-24 |
Family
ID=8857662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP010105766A AR031662A1 (es) | 2000-12-14 | 2001-12-12 | Nuevos derivados biciclicos de aminopirazinonas, su procedimiento de preparacion, composiciones farmaceuticas que las contienen y su utilizacion como inhibidores de proteasas de serina relacionadas con la tripsina |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6686358B2 (es) |
| EP (1) | EP1215213B1 (es) |
| JP (1) | JP3616599B2 (es) |
| KR (1) | KR100502251B1 (es) |
| CN (1) | CN1209363C (es) |
| AR (1) | AR031662A1 (es) |
| AU (1) | AU781614B2 (es) |
| BR (1) | BR0106129A (es) |
| CA (1) | CA2364199C (es) |
| CY (1) | CY1106376T1 (es) |
| DE (1) | DE60126046T2 (es) |
| DK (1) | DK1215213T3 (es) |
| EA (1) | EA004678B1 (es) |
| ES (1) | ES2280333T3 (es) |
| FR (1) | FR2818277B1 (es) |
| HK (1) | HK1047101B (es) |
| HU (1) | HUP0105328A3 (es) |
| MX (1) | MXPA01012895A (es) |
| NO (1) | NO322149B1 (es) |
| NZ (1) | NZ516129A (es) |
| PL (1) | PL351199A1 (es) |
| PT (1) | PT1215213E (es) |
| SI (1) | SI1215213T1 (es) |
| ZA (1) | ZA200110314B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040077605A1 (en) * | 2001-06-20 | 2004-04-22 | Salvati Mark E. | Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| EP1854798A3 (en) * | 2000-09-19 | 2007-11-28 | Bristol-Myers Squibb Company | Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| US20040087548A1 (en) | 2001-02-27 | 2004-05-06 | Salvati Mark E. | Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| AU2002364082A1 (en) * | 2001-12-19 | 2003-07-09 | Bristol-Myers Squibb Company | Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function |
| EP1523483A4 (en) * | 2002-06-26 | 2006-03-08 | Bristol Myers Squibb Co | AMINO-BICYCLIC PYRAZINONE AND PYRIDINONE FOR INHIBITING THE COOKING OF SERIN PROTEASE |
| FR2867780B1 (fr) * | 2004-03-19 | 2006-05-19 | Servier Lab | Nouveaux derives de 4-oxo-4,6,7,8-tetrahydropyrrolo (1,2-a) pyrazine-6-carboxamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| DE102018220624A1 (de) * | 2018-11-29 | 2020-06-04 | B. Braun Melsungen Ag | Wässrige Zusammensetzung, insbesondere zur Behandlung von Schleimhaut und/oder Wunden |
| US20250122225A1 (en) * | 2023-10-06 | 2025-04-17 | Omeros Corporation | Masp-2 inhibitors and methods of use |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05117276A (ja) * | 1991-10-23 | 1993-05-14 | Sumitomo Pharmaceut Co Ltd | 新規な３環性キノキサリンジオン誘導体 |
| MD970253A (ro) * | 1994-12-22 | 1999-05-31 | Biochem Pharma Inc. | Inhibitori biciclici micromoleculari ai trombinei |
| US6057314A (en) * | 1995-12-21 | 2000-05-02 | Biochem Pharma Inc. | Low molecular weight bicyclic thrombin inhibitors |
| WO1997048706A1 (en) * | 1996-06-18 | 1997-12-24 | Warner-Lambert Company | Pyrrolo[1,2-a]pyrazine-1,4-dione serine protease inhibitors |
| ES2191830T3 (es) * | 1996-10-24 | 2003-09-16 | Merck & Co Inc | Inhibidores de trombina. |
| US6011038A (en) * | 1997-09-05 | 2000-01-04 | Merck & Co., Inc. | Pyrazinone thrombin inhibitors |
| CA2348530A1 (en) * | 1998-10-30 | 2000-05-11 | Merck & Co., Inc. | Thrombin inhibitors |
| UA58636C2 (uk) * | 1999-06-04 | 2003-08-15 | Мерк Енд Ко., Інк. | Піразинонові інгібітори тромбіну, фармацевтична композиція, спосіб інгібування утворення тромбів у крові, спосіб лікування станів, пов'язаних із тромбоутворенням |
| FR2795072B1 (fr) * | 1999-06-15 | 2001-07-27 | Adir | Nouveaux derives bicycliques d'amino-pyrazinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
2000
- 2000-12-14 FR FR0016321A patent/FR2818277B1/fr not_active Expired - Fee Related
-
2001
- 2001-12-12 NO NO20016069A patent/NO322149B1/no unknown
- 2001-12-12 JP JP2001378235A patent/JP3616599B2/ja not_active Expired - Fee Related
- 2001-12-12 AR ARP010105766A patent/AR031662A1/es unknown
- 2001-12-13 DE DE60126046T patent/DE60126046T2/de not_active Expired - Fee Related
- 2001-12-13 CA CA002364199A patent/CA2364199C/fr not_active Expired - Fee Related
- 2001-12-13 SI SI200130692T patent/SI1215213T1/sl unknown
- 2001-12-13 ES ES01403227T patent/ES2280333T3/es not_active Expired - Lifetime
- 2001-12-13 EP EP01403227A patent/EP1215213B1/fr not_active Expired - Lifetime
- 2001-12-13 MX MXPA01012895A patent/MXPA01012895A/es not_active Application Discontinuation
- 2001-12-13 HU HU0105328A patent/HUP0105328A3/hu unknown
- 2001-12-13 DK DK01403227T patent/DK1215213T3/da active
- 2001-12-13 PT PT01403227T patent/PT1215213E/pt unknown
- 2001-12-13 NZ NZ516129A patent/NZ516129A/en unknown
- 2001-12-14 BR BR0106129-1A patent/BR0106129A/pt not_active IP Right Cessation
- 2001-12-14 ZA ZA200110314A patent/ZA200110314B/xx unknown
- 2001-12-14 US US10/020,433 patent/US6686358B2/en not_active Expired - Fee Related
- 2001-12-14 AU AU97230/01A patent/AU781614B2/en not_active Ceased
- 2001-12-14 CN CNB01143824XA patent/CN1209363C/zh not_active Expired - Fee Related
- 2001-12-14 PL PL01351199A patent/PL351199A1/xx not_active Application Discontinuation
- 2001-12-14 EA EA200101204A patent/EA004678B1/ru unknown
- 2001-12-14 KR KR10-2001-0079407A patent/KR100502251B1/ko not_active Expired - Fee Related
-
2002
- 2002-11-29 HK HK02108662.8A patent/HK1047101B/zh not_active IP Right Cessation
-
2007
- 2007-03-13 CY CY20071100352T patent/CY1106376T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR064730A1 (es) | Derivados de 2,4-dianilinopirimidinas, su preparacion, composiciones farmaceuticas y usos como inhibidores de ikk | |
| AR064732A1 (es) | Derivados de 2,4-dianilinopirimidinas, su preparacion, composiciones farmaceuticas y usos como inhibidores de ikk | |
| AR078152A1 (es) | Compuestos heterociclicos, utiles para el tratamiento de hcv y composiciones farmaceuticas que los comprenden | |
| AR006391A1 (es) | Compuesto de 6-fenilpiridil-2-amina y composiciones farmaceuticas del mismo | |
| AR050267A1 (es) | Derivados de urea ciclicos sustituidos con heterociclo, su preparacion y su uso farmaceutico como inhibidores de quinasa | |
| GT200600340A (es) | Inhibidores macrociclicos del virus de hepatitis c | |
| AR035205A1 (es) | Compuestos utiles en el tratamiento de enfermedades inflamatorias, proceso para su preparacion, intermediarios y composiciones farmaceuticas | |
| AR061835A1 (es) | Derivados tetraciclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| AR041883A1 (es) | Compuestos de piridopirimidinona, procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
| NI201000134A (es) | Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| AR042910A1 (es) | Compuestos de pirazolopirimidina y procedimiento para preparar el mismo y composiciones farmaceuticas que los contienen | |
| CO5021223A1 (es) | Compuestos calciliticos calciliticos | |
| CO6230990A2 (es) | Nuevos derivados triciclicos su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| GT200700084A (es) | Derivados de indanil-piperazinas, su procedimiento de preparación y las composiciones farmaceuticas que los contienen. | |
| AR031662A1 (es) | Nuevos derivados biciclicos de aminopirazinonas, su procedimiento de preparacion, composiciones farmaceuticas que las contienen y su utilizacion como inhibidores de proteasas de serina relacionadas con la tripsina | |
| AR041882A1 (es) | Compuestos de imidazopiridina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
| CR9499A (es) | Nuevos derivados de fenilpiridinilpiperazina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| AR041218A1 (es) | Derivados de indolilo, un proceso para su preparacion, composicion farmaceutica que lo contiene y uso del compuesto para preparar un medicamento | |
| AR053453A1 (es) | Derivados de aminoalquil- y amidoalquil-benzopirano substituidos | |
| AR045090A1 (es) | Derivados de nicotinamida utiles como inhibidores de pde4 | |
| AR029468A1 (es) | Derivados de aminoacidos n-mercaptoacilados, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| ECSP088455A (es) | Nuevos derivados de indolizina, su proceso de preparación y las composiciones terapéuticas que los comprenden | |
| ES2174582T3 (es) | Nuevos derivados de 1,2-ditiolano, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| AR038443A1 (es) | Derivados de aminoacidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| AR061740A1 (es) | Nuevos derivados naftalenicos, su procedimiento de praparacion y las composiciones farmaceuticas que los contienen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |